These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 239460)

  • 81. Studies on human factor IX by immunoelectrophoretic and immunodiffusion methods.
    Hemmendorff B; Borg H; Linder A; Andersson LO
    Thromb Res; 1978 Jan; 12(1):131-9. PubMed ID: 417421
    [No Abstract]   [Full Text] [Related]  

  • 82. Improved virus safety and purity of a chromatographically produced factor IX concentrate by nanofiltration.
    Hoffer L; Schwinn H; Biesert L; Josic D
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):187-96. PubMed ID: 7581895
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Further studies on the activation of factor IX by activated factor XI.
    Kingdon HS; Davie EW
    Thromb Diath Haemorrh Suppl; 1965; 17():15-22. PubMed ID: 5874832
    [No Abstract]   [Full Text] [Related]  

  • 84. Effect of intermediates of extrinsic clotting on purified factor XI: factor VII and/or thromboplastin.
    Schiffman S; Markland FS
    Thromb Res; 1975 Mar; 6(3):273-9. PubMed ID: 234640
    [No Abstract]   [Full Text] [Related]  

  • 85. A technique for specific removal of factor IX alloantibodies from human plasma: partial characterization of the alloantibodies.
    Theodorsson B; Hedner U; Nilsson IM; Kisiel W
    Blood; 1983 May; 61(5):973-81. PubMed ID: 6338979
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Activation of factor IX by thrombin preparations in the absence of factor XI.
    Irwin JF; Mammen EF
    Thromb Res; 1976 Feb; 8(2):141-9. PubMed ID: 814650
    [No Abstract]   [Full Text] [Related]  

  • 87. G- and C-bands in human chromosomes treated with snake venoms.
    Garcia Ruíz IR; Beçak W
    Mem Inst Butantan; 1975; 39():123-33. PubMed ID: 17807
    [No Abstract]   [Full Text] [Related]  

  • 88. STUDY ON THE ANTIGENICITY OF THE HUMAN NONHEMOGLOBIN PROTEINS.
    HITSUMOTO S; KUMAMOTO T; SAWAMURA O; HATTORI K
    Kyushu J Med Sci; 1964 Dec; 15():77-85. PubMed ID: 14290455
    [No Abstract]   [Full Text] [Related]  

  • 89. Role of magnesium in factor XIa catalyzed activation of factor IX: calcium binding to factor IX under physiologic magnesium.
    Agah S; Bajaj SP
    J Thromb Haemost; 2009 Aug; 7(8):1426-8. PubMed ID: 19500239
    [No Abstract]   [Full Text] [Related]  

  • 90. Bleeding due to deficiency of plasma thromboplastin antecedent (PTA) and plasma thromboplastin component (PTC): report of nine cases.
    STEG RF; GORES RJ; THOMPSON JH; OWEN CA
    Oral Surg Oral Med Oral Pathol; 1960 Jun; 13():671-7. PubMed ID: 13834027
    [No Abstract]   [Full Text] [Related]  

  • 91. Interaction of factor XI and sulfatide.
    Schiffman S; Rosenfeld R; Retzios AD
    Thromb Res; 1986 Feb; 41(4):575-80. PubMed ID: 3961736
    [No Abstract]   [Full Text] [Related]  

  • 92. Physicochemical and immunological properties of canine factor X and activated factor X.
    Arai H; Takeda Y
    Thromb Res; 1977 Sep; 11(3):357-64. PubMed ID: 411192
    [No Abstract]   [Full Text] [Related]  

  • 93. Plasma thromboplastin component (PTC) potency of plasma fractions.
    WHITE SG; AGGELER PM; EMERY BE
    Proc Soc Exp Biol Med; 1953 May; 83(1):69-71. PubMed ID: 13064179
    [No Abstract]   [Full Text] [Related]  

  • 94. Cases Illustrative of Diseases of the Ear: No. IX.
    Anderson TM
    Glasgow Med J; 1865 Oct; 13(51):291-297. PubMed ID: 30432462
    [No Abstract]   [Full Text] [Related]  

  • 95. IX. Treatment of Wounds of the Heart: With Report of Two Cases.
    Kirchner WC
    Ann Surg; 1910 Jul; 52(1):96-110. PubMed ID: 17862564
    [No Abstract]   [Full Text] [Related]  

  • 96. Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI.
    Kearney KJ; Butler J; Posada OM; Wilson C; Heal S; Ali M; Hardy L; Ahnström J; Gailani D; Foster R; Hethershaw E; Longstaff C; Philippou H
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33397811
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The evolution of factor XI and the kallikrein-kinin system.
    Ponczek MB; Shamanaev A; LaPlace A; Dickeson SK; Srivastava P; Sun MF; Gruber A; Kastrup C; Emsley J; Gailani D
    Blood Adv; 2020 Dec; 4(24):6135-6147. PubMed ID: 33351111
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways.
    Noubouossie DF; Henderson MW; Mooberry M; Ilich A; Ellsworth P; Piegore M; Skinner SC; Pawlinski R; Welsby I; Renné T; Hoffman M; Monroe DM; Key NS
    Blood; 2020 Mar; 135(10):755-765. PubMed ID: 31971571
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency.
    Saes JL; Schols SEM; Betbadal KF; van Geffen M; Verbeek-Knobbe K; Gupta S; Hardesty BM; Shapiro AD; van Heerde WL
    Haemophilia; 2019 Nov; 25(6):1073-1082. PubMed ID: 31469483
    [TBL] [Abstract][Full Text] [Related]  

  • 100. An improved yeast surface display platform for the screening of nanobody immune libraries.
    Uchański T; Zögg T; Yin J; Yuan D; Wohlkönig A; Fischer B; Rosenbaum DM; Kobilka BK; Pardon E; Steyaert J
    Sci Rep; 2019 Jan; 9(1):382. PubMed ID: 30674983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.